Testing a treatment made from a patient's own immune cells for glioblastoma that has come back
Original title: Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a study in people that has not listed a trial phase, so it is still early.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether a patient's own immune cells, grown and given back, can help against glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary that has returned.
Who this trial is for. This trial is for people whose glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary has come back after treatment. It tests CHANK-101, a therapy made from each patient's own natural killer cells, a type of immune cell.
Where it stands. The trial has not reported any results yet. The main thing it will measure is how long people live before the tumor grows again. It will also look at safety, side effects, and how long people live overall.
What this means, and what it doesn't
What it could mean: Researchers are looking for new options for glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary that has come back. If you or someone you care for has this tumor, you could ask your care team whether a study like this might fit. Only the trial team can decide who is able to join.
What it doesn't mean: This is a test, not a proven treatment. We do not yet know if it is safe or if it works. Being in a trial does not promise that it will help. This is not a cure.
Source: ClinicalTrials.gov, September 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.